Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mary S. Barrett"'
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 34:99-102
Campylobacter jejuni is an important pathogen that causes gastroenteritis, as well as other disease states such as meningitis and septic arthritis. In this study, the Etest (AB BIODISK, Solna, Sweden) results were compared to a reference agar dilutio
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 33:275-282
The use of macrolides for treatment of respiratory complaints has been complicated by susceptibility test conditions that adversely effect the in vitro test results and perceived potencies of these compounds. Dirithromycin was studied as to its in vi
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 32:45-50
BAY 12-8039 or moxifloxacin is a new 8-methoxyquinolone with documented, improved activity against Gram-positive cocci and anaerobic bacteria. This study tested 1250 commonly isolated respiratory tract pathogens (251 Moraxella catarrhalis, 499 Haemop
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 31:573-578
Cefditoren (formerly ME-1206), a new orally administered cephalosporin, was evaluated in vitro against 1249 recently isolated strains of Streptococcus pneumoniae (500 strains), Moraxella catarrhalis (250 strains), and Haemophilus influenzae (499 stra
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 31:349-353
The activity of two ketolide compounds, HMR 3004 and 3647, were compared to those of five macrolides, quinupristin/dalfopristin, ciprofloxacin, and ampicillin. The rate of killing for the ketolides was also assessed against Haemophilus influenzae and
Autor:
Ronald N. Jones, Mary S. Barrett
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 30:135-138
Levofloxacin bactericidal activity was compared to ciprofloxacin and ofloxacin against 10 strains of Moraxella catarrhalis. The cidal action (by kill-curve analysis) was slightly more rapid for levofloxacin, but all tested fluoroquinolones were consi
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 28:193-200
Trovafloxacin, a new fluorinated naphthyridine, has enhanced activity against Gram-positive cocci, while retaining an excellent spectrum against Gram-negative pathogens. It has been used successfully in clinical trials for therapy of gonorrhea, and t
Publikováno v:
Journal of Clinical Microbiology. 35:2083-2086
Mycobacterium marinum, a well-recognized cutaneous pathogen, is usually treated by chemotherapy without available standardized in vitro susceptibility testing information. In this study, we have attempted to apply the stable-gradient method (Etest; A
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 25:107-112
Detection of oxacillin-resistance in staphylococci by phenotypic methods remains problematic. Although standardized susceptibility test methods are adequate for Staphylococcus aureus, many are less satisfactory for the coagulase-negative staphylococc
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 19:93-99
Preliminary susceptibility testing interpretive criteria were determined for two investigational drugs, DU-6859a and FK-037, when tested against Haemophilus influenzae and Neisseria gonorrhoeae strains. National Committee for Clinical Laboratory Stan